HOOKIPA Pharma is a clinical-stage biopharmaceutical company developing immunotherapeutics based on a proprietary arenavirus platform designed to amplify T cell and immune responses. Its pipeline includes HB-700 (multi-KRAS mutant-targeting immunotherapy), eseba-vec/HB-200 (HPV16+ head and neck cancer), HB-400 (Hepatitis B), and HB-500 (HIV), with infectious disease programs partnered with Gilead Sciences. The company uses replicating and non-replicating arenavirus technologies to induce antigen-specific CD8+ T cell responses.
Q2 FY2026 — expected 2026-07-19
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-02-28 | 2024-12-31 | 0001558370-25-001853 | EDGAR | 119K words |
| 2024-03-22 | 2023-12-31 | 0001558370-24-003738 | EDGAR | 117K words |
| 2023-03-15 | 2022-12-31 | 0001558370-23-003778 | EDGAR | — |
| 2022-03-24 | 2021-12-31 | 0001558370-22-004211 | EDGAR | — |
| 2021-03-18 | 2020-12-31 | 0001558370-21-003176 | EDGAR | — |
| 2020-03-19 | 2019-12-31 | 0001558370-20-002928 | EDGAR | — |
| Filed | Period | Accession | Source | Full Text |
|---|---|---|---|---|
| 2025-05-15 | 2025-03-31 | 0001558370-25-007871 | EDGAR | 29K words |
| 2024-11-14 | 2024-09-30 | 0001558370-24-015711 | EDGAR | 34K words |
| 2024-08-08 | 2024-06-30 | 0001558370-24-011647 | EDGAR | 32K words |
| 2024-05-09 | 2024-03-31 | 0001558370-24-007463 | EDGAR | 27K words |
| 2023-11-09 | 2023-09-30 | 0001558370-23-018412 | EDGAR | 29K words |
| 2023-08-10 | 2023-06-30 | 0001558370-23-014392 | EDGAR | 28K words |
| 2023-05-11 | 2023-03-31 | 0001558370-23-009258 | EDGAR | — |
| 2022-11-14 | 2022-09-30 | 0001558370-22-017566 | EDGAR | — |
| 2022-08-11 | 2022-06-30 | 0001558370-22-013174 | EDGAR | — |
| 2022-05-16 | 2022-03-31 | 0001558370-22-008855 | EDGAR | — |
| 2021-11-10 | 2021-09-30 | 0001558370-21-015390 | EDGAR | — |
| 2021-08-12 | 2021-06-30 | 0001558370-21-011473 | EDGAR | — |
| Filed | Accession | Source | Full Text |
|---|---|---|---|
| 2025-07-29 | 0001104659-25-071716 | EDGAR | 1K words |
| 2025-07-18 | 0001104659-25-069029 | EDGAR | 1K words |
| 2025-05-22 | 0001104659-25-051841 | EDGAR | 39K words |
| 2025-02-20 | 0001104659-25-015647 | EDGAR | 1K words |
| 2025-01-29 | 0001104659-25-007015 | EDGAR | 3K words |
| 2025-01-10 | 0001104659-25-002517 | EDGAR | 3K words |
| 2025-01-07 | 0001104659-25-001553 | EDGAR | 3K words |
| 2025-01-02 | 0001104659-25-000020 | EDGAR | 7K words |
| 2024-11-20 | 0001104659-24-121019 | EDGAR | 1K words |
| 2024-11-14 | 0001558370-24-015708 | EDGAR | 2K words |
118 total filings indexed. 90 additional filings (S-1, DEF 14A, etc.) View all (JSON) · SEC EDGAR
| CIK | 0001760542 |
| Ticker | HOOK |
| Exchange | OTC |
| SIC | 2834: Pharmaceutical Preparations |
| Incorporated | DE |
This is a static snapshot. For live, structured JSON with cryptographic provenance chain:
MCP (recommended for AI): claude mcp add origin --transport http https://origin.rootz.global/mcp
Try it — paste this into your AI:
Works in ChatGPT, Claude, Gemini, or any AI. Free, structured, cryptographically signed — ~500 tokens vs 130,000 scraping an IR site.
claude mcp add origin --transport http https://origin.rootz.global/mcpGET https://origin.rootz.global/api/company/HOOK (~200 tokens, structured JSON with cryptographic provenance)